Eveon stands by its commitments

February 01 2010 - Eveon has taken a key step towards the implementation of its development plan in raising more than €2 million... Eveon's news - Actualités Eveon -

The company

Eveon is the greek transcription of ενεση which means 'injection'.

Welcome to Eveon

This is the story of a mosquito that stings at the right depth, injects its anti-coagulant, and pumps few drops of blood thanks to its 5 sensors and its 2 pumps. How to mimic the surprising performance of the mosquito in an automatic drug injection system ? So was born the idea of the device Eveon. In 2007 the idea becomes a project of a company, incubated in GRAIN and receives the 'Emergence' price at the 9th national competition to support the creation of company of innovative technologies from the Ministry for Education and Research.

Created in December, 2008, Eveon dedicates itself to the design of injection medical devices totally innovatives from the specifications of its clients, the pharmaceutical and biotech laboratories... Eveon Company presentation - Présentation de la société Eveon -

Biomedical Diagnostics (BMD) : CE mark for its LISA TRACKER Premium kits

Paris, May 6, 2010 - Biomedical Diagnostics (BMD), an in vitro diagnostics company specializing in the diagnosis of autoimmune diseases, today announced that its LISA TRACKER Premium kits had obtained CE mark approval.
The LISA TRACKER Premium kits are innovative monitoring tools for the simultaneous assay of TNFα (a cytokine involved in disease progression), anti-TNF therapeutics (Infliximab, Etanercept and Adalimumab) and neutralizing, anti-drug antibodies (ADAs). The correlation of these three parameters is essential for defining and predicting a patient's treatment response. It known that the development of ADAs reduces a treatment's efficacy and induces the long-term resurgence of disease symptoms. In combination with clinical data, the assay results enable physicians to establish the patient's resistance profile and thus optimize the management of certain autoimmune diseases (such as chronic rheumatoid arthritis and ankylosing spondylitis in rheumatology, Crohn's disease and hemorrhagic colitis in gastroenterology and psoriatic arthritis in dermatology)...

...

...About Biomedical Diagnostics (BMD):
With more than twenty years’ experience in the in vitro diagnostics (IVD) market, BMD has acknowledged expertise in the development, production and marketing of high quality, innovative products. The company develops and supplies effective high throughput solutions, based notably on Luminex® technology for the diagnosis of auto immune diseases. BMD is now aiming to become France's leading distributor of innovative IVD products. By building on its strength in the autoimmune disease testing market, the company is building a reputation as a major European player in the development of "companion" diagnostics as part of a pro-active strategy for partnering with biotech and pharma companies... Biomedical Diagnostics' Press Release - communiqué de presse Biomedical Diagnostics en français -

PhysioStim : 10 years in 2010!

02/11/2010 — PhysioStim celebrates 10 years in 2010! - PhysioStim set up un 2000, counts 11 employees in 2010 and a 10 years expertise in cardiac safety pharmacology...

Physiostim was created in 2000, on a sun-kissed ground where grows the pink garlic. There were only two at that time, now we are more than 10 people working together.

First and foremost, Physiostim is a human adventure. More and more clients all over the world rely on our recognized expertise and know-how.

For the next decade, we wish to keep on getting bigger and of course keeping the values that we have been leaning upon for 10 years. - PhysioStim Homepage - (french version - version française)-

Overview

PhysioStim has the relevant expertise to help you.

Since 2000, PhysioStim – one of the European’s most reliable French CRO (Contract Research Organisation) –has never ceased to improve its expertise in cardiac safety pharmacology.

Indeed, PhysioStim’s experts offer electrophysiological studies, preclinical resources as well as their dedicated expertise in answering ICHS7A and S7B guidelines in accordance with GLPs (Good Laboratory Practices).

PhysioStim therefore offers a wide range of services and consequently improves the quality of work... - PhysioStim Overview -

Launching of the Medex website

22-02-2010 - Launching of the Medex website - Medex is determined to strengthen its presence on the Internet... Medex's News - Actualités de Medex -

About Medex

Medex is a biomedical laboratory established in 1988. Its operations are based in Saint Priest near Lyon (France).

Its products are sold in more than 10 countries.

Medex is specialised in contrast media injectors and medical disposables. The company offers injectors for CT and angiography examinations. It also has a large and comprehensive offering of disposables for CT and angiography examinations in addition to a selected range for MRI.

Medex is known on the market for its innovations :

- Soft Bag Injector, the only bag injector available on the market;
- Secufill in the safety patient line with its patented double threshold valve.
In 2004, Guerbet a pharmaceutical group specialised in medical imaging, acquired Medex in order to develop a global offering that now includes Soft Bag Injector and a new packaging for contrast media, Xenetix® in ScanBag®... About Medex - version française Medex by Guerbet -